Market Overview

Trade GMED stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
12/18/18Credit SuisseInitiates Coverage OnOutperform53.0
12/17/18Credit SuisseInitiates Coverage OnOutperform53.0
11/28/18UBSInitiates Coverage OnNeutral55.0
Show more Loading articles...

Earnings View Earnings

Q3 2018 EST Actual Surprise
EPS: 0.32 0.39 0.07
Rev: 167.54M 169.24M 1.70M
Q4 2018 EST Actual Surprise
EPS: Expected
2019-02-20
Rev:

Company Profile